Oropharyngeal Cancer Diagnosis and Therapeutics Market Research and Analysis Report 2018

Global Oropharyngeal Cancer Diagnosis and Therapeutics Industry

New Study On “2018-2023 Oropharyngeal Cancer Diagnosis and Therapeutics Market Global Key Player, Demand, Growth, Opportunities And Analysis Forecast” Added To Wise Guy Reports Database

Oropharyngeal cancer is a malignant tumour that starts in the cells of the oropharynx. Rising prevalence of oropharyngeal cancer has been the major factor driving the market growth. More than 400,000 incidences of oropharyngeal cancer are reported every year globally. Additionally, increasing geriatric population and rising oropharyngeal cancer associated with them is another factor driving the market growth. Moreover, growing number of smokers and alcohol consumers which are most prone to this cancer has been a major factor for the market growth. Around 1.1 billion people smoked tobacco in 2015 and more than 2 billion people consumed alcoholic drinks globally. Such high number reflects a high chance of oropharyngeal cancer in the consumers.

Try Sample Report @    https://www.wiseguyreports.com/sample-request/3186929-global-oropharyngeal-cancer-diagnosis-and-therapeutics-market-research

High costs of oropharyngeal cancer treatment along with low awareness towards this cancer act as major restraints for the market growth. However, ongoing improvements in the healthcare expenditure from government and availability of reimbursements is factor augmenting the market growth. Additionally, rising number of minimally invasive surgeries for treatment of the cancer is expected to drive the future market growth. At present, Transoral laser microsurgery and Transoral robotic surgery are widely adopted minimally invasive surgeries for treatment of oropharyngeal cancer.

On the basis of the geography, oropharyngeal cancer market is segmented into North America, Asia Pacific, Europe and Rest of the World. North America has been predicted to dominate the global oropharyngeal cancer market due to well established health infrastructure and high prevalence of this cancer towards people. Additionally, APAC will be the fastest growing region during the fastest growing period due to rising geriatric population and increasing incidence and prevalence rate of oropharyngeal cancer.

The Key Players in the Oropharyngeal cancer market are Merck & Co., GE Healthcare, Synta Pharmaceuticals Corp, VLPbio, Novartis AG, Immunovaccines, Inc., Inovio Pharmaceuticals and others. These players adopt various strategies such as partnership, R&D, M&A, product launch and joint ventures to create for more market opportunities. Inovio Pharmaceuticals has a clinical collaboration with the Parker Institute for Cancer Immunotherapy in January, 2018 to design innovative studies having the potential to address cancers with high unmet need.

Global Oropharyngeal cancer market can be segmented on the basis of diagnosis type, treatment type and end-users. On the basis of diagnosis type, the market can be further segmented into endoscopy, biopsy and imaging (MRI Scan, CT-Scan, PET-CT Scan). The market has been segmented on the basis of treatment type into surgery, chemotherapy, radiation therapy, targeted therapy and others. Moreover, the market has been segmented on the basis of end-users into hospitals, ambulatory surgery centers and others.

The Report covers

Comprehensive research methodology of Global Oropharyngeal Cancer Market.
This report also includes detailed and extensive market overview with current market recommendations & key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Oropharyngeal Cancer Market.
Insights about market determinants which are stimulating the Global Oropharyngeal Cancer Market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3186929-global-oropharyngeal-cancer-diagnosis-and-therapeutics-market-research

 Some points from table of content:

1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. RISING PREVALENCE OF OROPHARYNGEAL CANCER
3.1.2. AVAILABILITY OF SEVERAL REIMBURSEMENT POLICIES
3.1.3. INCREASING CONSUMPTION OF TOBACCO AND OTHER PRODUCTS
3.1.4. ESCALATING NUMBER OF HUMAN PAPILLOMAVIRUS (HPV) INFECTION
3.1.5. RISING GERAITRIC POPULATION AND OROPHARYNEGAL INCIDENCES ASSOCIATED WITH THEM
3.2. RESTRAINTS
3.2.1. HIGH COST OF TREATMENT
3.2.2. LESS AWARENESS CONCERNING OROPHARYNGEAL CANCER AND ITS TREATMENT IN DEVELOPING COUNTRIES
3.3. OPPORTUNITY
3.3.1. EMERGING DEMAND IN APAC REGION DUE TO RISING INCIDENCES
3.3.2. GROWING NUMBER OF MINIMAL INVASIVE SURGERIES
4. MARKET SEGMENTATION
4.1. BY DIAGNOSIS TYPE
4.1.1. ENDOSCOPY
4.1.2. BIOPSY
4.1.3. IMAGING
4.1.4. MRI SCAN
4.1.5. CT SCAN
4.1.6. PET-CT SCAN
4.2. BY TREATMENT TYPE
4.2.1. SURGERY
4.2.2. CHEMOTHERAPY
4.2.3. RADIATION THERAPY
4.2.4. TARGETED THERAPY
4.2.5. OTHERS
4.3. BY END-USERS
4.3.1. HOSPITALS
4.3.2. AMBULATORY SURGERY CENTRES
4.3.3. OTHERS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.1.3. REST OF NORTH AMERICA
6.2. EUROPE
6.2.1. UNITED KINGDOM
6.2.2. FRANCE
6.2.3. GERMANY
6.2.4. ITALY
6.2.5. SPAIN
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. REST OF ASIA PACIFIC
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. AB SCIENCES
7.2. ADVAXIS INC.
7.3. ASTRAZENECA PLC
7.4. BAYER AG
7.5. BOSTON BIOMEDICAL
7.6. BRISTOL-MYERS SQUIBB COMPANY
7.7. GE HEALTHCARE
7.8. GENTICEL S.A.
7.9. IMMUNOVACCINE, INC.
7.10. INOVIO PHARMACEUTICALS
7.11. KOLLTAN PHARMACEUTICALS INC.

Continued…….

For more information or any query mail at [email protected]

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Posted by Vivian Dsena on Tuesday July 10 2018, 5:25 AM EDT. All trademarks acknowledged. Filed under Uncategorized. Comments and Trackbacks closed. Follow responses: RSS 2.0